Catalyst Biosciences Price Prediction
| CBIODelisted Stock | USD 0.41 0.02 4.65% |
Oversold Vs Overbought
65
Oversold | Overbought |
Using Catalyst Biosciences hype-based prediction, you can estimate the value of Catalyst Biosciences from the perspective of Catalyst Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Catalyst Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Catalyst because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Catalyst Biosciences after-hype prediction price | USD 0.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Catalyst |
Catalyst Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Catalyst Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Catalyst Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Catalyst Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Catalyst Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Catalyst Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Catalyst Biosciences' historical news coverage. Catalyst Biosciences' after-hype downside and upside margins for the prediction period are 0.41 and 0.41, respectively. We have considered Catalyst Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Catalyst Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Catalyst Biosciences is based on 3 months time horizon.
Catalyst Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Catalyst Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Catalyst Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Catalyst Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 3 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.41 | 0.41 | 0.00 |
|
Catalyst Biosciences Hype Timeline
Catalyst Biosciences is currently traded for 0.41. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Catalyst is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Catalyst Biosciences is about 0.0%, with the expected price after the next announcement by competition of 0.41. About 28.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.53. Some equities with similar Price to Book (P/B) outperform the market in the long run. Catalyst Biosciences has Price/Earnings To Growth (PEG) ratio of 0.02. The entity recorded a loss per share of 1.5. The firm last dividend was issued on the 13th of January 2023. Catalyst Biosciences had 1:15 split on the 13th of February 2017. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.Catalyst Biosciences Related Hype Analysis
Having access to credible news sources related to Catalyst Biosciences' direct competition is more important than ever and may enhance your ability to predict Catalyst Biosciences' future price movements. Getting to know how Catalyst Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Catalyst Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HTGM | HTG Molecular Diagnostics | (0.06) | 7 per month | 0.00 | (0.13) | 25.00 | (20.00) | 65.45 | |
| BLPH | Bellerophon Therapeutics | 0.00 | 0 per month | 0.00 | (0.18) | 7.64 | (14.34) | 105.97 | |
| AKTX | Akari Therapeutics PLC | (0.05) | 6 per month | 0.00 | (0.28) | 4.84 | (12.59) | 47.27 | |
| BNTC | Benitec Biopharma Ltd | (0.84) | 6 per month | 3.49 | 0.03 | 7.89 | (4.52) | 29.78 | |
| PULM | Pulmatrix | 1.01 | 3 per month | 3.24 | 0.18 | 12.29 | (4.76) | 92.85 |
Catalyst Biosciences Additional Predictive Modules
Most predictive techniques to examine Catalyst price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Catalyst using various technical indicators. When you analyze Catalyst charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Catalyst Biosciences Predictive Indicators
The successful prediction of Catalyst Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Catalyst Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Catalyst Biosciences based on analysis of Catalyst Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Catalyst Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Catalyst Biosciences's related companies.
Story Coverage note for Catalyst Biosciences
The number of cover stories for Catalyst Biosciences depends on current market conditions and Catalyst Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Catalyst Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Catalyst Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Catalyst Biosciences Short Properties
Catalyst Biosciences' future price predictability will typically decrease when Catalyst Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Catalyst Biosciences often depends not only on the future outlook of the potential Catalyst Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Catalyst Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.5 M | |
| Cash And Short Term Investments | 21.7 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |